Aptus Pharma Limited Share Price

Aptus Pharma Limited Share Price

BSE: 544529
|
Pharmaceuticals
|
S Cap
₹ 333.20
-₹6.80 (-2%)
1D
Last updated 10 Sep, 2026, 12:15 IST

Aptus Pharma Limited Share Price Today

As of 10 Sep 2026, Aptus Pharma Limited share price is ₹333.20. The stock opened at ₹341.70, compared to its previous close of ₹340.00. During today's trading session, Aptus Pharma Limited share price moved in the range of ₹333.20 to ₹341.70, with an average price of ₹337.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹32.32 and a high of ₹341.70.

₹333.20
2.00% down today
₹341.70
1D LOW
1D HIGH

Aptus Pharma Limited Returns Calculator

Circuit
L
H
₹333.20
₹346.80
52-week
L
H
₹32.32
₹341.70

About Aptus Pharma Limited

Aptus Pharma Limited Share Price
ISIN
INE15XJ01010
Sector Market Cap
₹ 571.70 Cr

Aptus Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing a range of medicine solutions which include Anti-Infectives, Antacids and PPI, G.I. Medicines, Anti-Allergic and Respiratory Medicine, Nutritional Supplements, Anti-Inflammatory and Pain Management, Neuro-Psychiatric Medicine, Lipid Lowering Medicine, Anti-Hypertensives and Cardiovascular Medicine, Antidiabetic Medicine, and Consumer Care. Its divisions include Aptus Pharma, Aptus CD Care, Aptus WellCare, and Aptus Global. Its brands include Chilkul, Koltus, Telbira, and Aptirub. Its products include APBILE-150, APBILE-300, APORA 5 CREAM, APTICHYM-FORTE, APTIDA-10, APTIDA-M, APTIDOL-MR, APTIDOX-L, APTIFRESH, APTIFRESH-EC, APTIFRESH-FM, APTIFRESH-LE, APTIFRESH-MD, APTIFRESH-MW, APTIGLIM-M1 FORTE, APTIGLIM-M1 PR, APTIGLIM-M2 FORTE, APTIGLIM-M2 SR, among others.

Aptus Pharma Limited Financial Highlights

  • Revenue: Aptus Pharma Limited reported revenue of ₹46.70 crore in FY26 vs ₹24.64 crore in FY25. It showed an increase of 89.53% on a yearly basis.
  • Operating Profit: Aptus Pharma Limited reported an operating profit of ₹6.37 crore in FY26 vs ₹4.20 crore in FY25. It showed an increase of 51.67% on a year-on-year basis.
  • Net Profit: Aptus Pharma Limited reported a net profit of ₹4.62 crore in FY26 vs ₹2.96 crore in FY25. It showed an increase of 56.08% on a yearly basis.
Know more
Promoters
72.89%
FII
0.00%
Other DII
0.00%
Retail and other
27.11%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
May 20260.00%
Jun 20260.00%
Mkt Cap Cr
571.70
P/E
51.88
P/B
24.98
ROE
19.79%
D/E
0.31
ROCE
23.50%
Div. Yield
0.00%
EPS(TTM)
7.78
Turnover
1.92
EV/EBITDA
32.41
Net Margin
9.92%
Op. Margin
16.28%
ROA
14.96%
Quick Ratio
1.12
Curr. Ratio
2.79
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Aptus Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Aptus Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,51,339.0037.005.3613.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,54,068.0086.0715.0215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,87,594.0087.0122.3125.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,12,618.0024.524.1518.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,515.0032.933.2111.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,04,456.0095.8019.7116.77%0.4016.14%97.200.10%0.6713.72
Aurobindo Pharma97,008.7026.212.579.25%0.1911.76%394.820.24%0.3841.58
Lupin95,660.0017.234.2623.76%0.0424.88%659.000.86%0.57129.18
Dr. Reddy's Laboratories96,113.4029.972.5111.07%0.1812.54%377.950.70%0.4138.68
Mankind Pharma93,596.0045.275.7411.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Aptus Pharma Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹46.57₹24.56₹17.86₹13.90
Other Income₹0.13₹0.08₹0.03₹0.00
Total Revenue₹46.71₹24.64₹17.88₹13.90
Total Expenses₹40.33₹20.44₹16.76₹13.60
Profit Before Tax₹6.37₹4.20₹1.12₹0.30
Tax₹1.75₹1.10₹0.32₹0.10
Profit After Tax₹4.62₹3.10₹0.80₹0.19
EPS - Basic₹7.78₹6.37₹5.32₹1.30
EPS - Diluted₹7.78₹6.37₹5.32₹1.30

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹4.62₹3.10₹1.12₹0.30
Income before WC changes₹7.45₹4.85₹1.55₹0.62
Change in Assets-₹19.69-₹7.22-₹3.30-₹1.75
Change in Liabilities₹7.82₹1.64-₹0.08₹1.07
Change in WC-₹11.86-₹5.57-₹3.38-₹0.68
Cash flow from Operations-₹5.60-₹1.84-₹2.17-₹0.18
Cash flow from Investing-₹6.37-₹0.54-₹0.30-₹0.35
Cash flow from Financing₹7.79₹6.68₹2.86₹0.81
Total Cash Flow-₹4.19₹4.30₹0.38₹0.28
Cash (Start of the year)₹5.21₹0.91₹0.54₹0.26
Cash (End of the year)₹1.03₹5.21₹0.91₹0.54

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹8.30₹2.18₹1.70₹0.56
Current Assets₹35.24₹19.74₹8.32₹5.65
Total Assets₹43.53₹21.92₹10.03₹6.22
Current Liabilities₹19.31₹12.08₹4.14₹3.13
Net Current Asset₹15.93₹7.65₹4.19₹2.52
Non-Current Liabilities₹0.88₹2.87₹4.12₹2.12
Equity Capital₹23.35₹6.97₹1.77₹0.97
Total Equity & Liabilities₹43.53₹21.92₹10.03₹6.22
* All values are in INR Crore
Qty
Bid
800
333.25
1200
333.2
0
0
0
0
0
0
Ask
Qty
333.2
14800
334.85
400
341.7
800
346.5
400
346.8
8000
Bid Total: 2000
Ask Total: 24400
Buy orders: 8%
Sell orders: 92%
Bearish
5
Neutral
1
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
77.42
Bullish
ATR (14)
6.6
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
99.2
Bearish
ADX(9)
58.89
Bearish
UO(9)
80.32
Bearish
ROC(12)
14.71
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
326.97
329.09
10D
320.74
320.37
20D
301.67
306.89
50D
273.36
277.11
100D
232.75
241.11
Volume trend — traded volume by day
10 Sep0L
9 Sep0L
8 Sep0L
7 Sep0L
4 Sep0L
3 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Aptus Pharma Limited Share Price
Aptus Pharma Limited
Pharmaceuticals
Add Stock
Add Another

Aptus Pharma Limited Share Price FAQs

Aptus Pharma Limited share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837